Achilles Therapeutics Plc has appointed James Taylor as chief business officer and Cassian Yee as a member of its scientific advisory board as it advances its T cell therapies for solid tumours. Mr Taylor joins from Sosei Heptares where he was also CBO and led business deals with multiple pharma companies including a 2021 licensing agreement with Neurocrine Biosciences Inc in neurology. Prior to this, he was a senior director at GlaxoSmithKline Plc. Dr Yee is a professor in the department of melanoma medical oncology and the department of immunology at the MD Anderson Cancer Center in the US.
Achilles Therapeutics Plc announced the appointments on 30 June 2022.
Copyright 2022 Evernow Publishing Ltd